A detailed history of Lawson Kroeker Investment Management Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Lawson Kroeker Investment Management Inc holds 5,650 shares of ABBV stock, worth $970,274. This represents 0.22% of its overall portfolio holdings.

Number of Shares
5,650
Previous 5,759 1.89%
Holding current value
$970,274
Previous $987,000 12.97%
% of portfolio
0.22%
Previous 0.2%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$163.84 - $199.33 $17,858 - $21,726
-109 Reduced 1.89%
5,650 $1.12 Million
Q1 2024

Apr 22, 2024

SELL
$159.82 - $182.1 $18,059 - $20,577
-113 Reduced 1.92%
5,759 $1.05 Million
Q4 2023

Jan 29, 2024

SELL
$137.6 - $154.97 $6,192 - $6,973
-45 Reduced 0.76%
5,872 $909,000
Q2 2023

Jul 24, 2023

SELL
$132.51 - $164.9 $26,502 - $32,980
-200 Reduced 3.27%
5,917 $797,000
Q1 2023

Apr 20, 2023

BUY
$144.61 - $166.54 $362,103 - $417,016
2,504 Added 69.31%
6,117 $974,000
Q2 2022

Jul 11, 2022

SELL
$137.62 - $174.96 $17,890 - $22,744
-130 Reduced 3.47%
3,613 $553,000
Q1 2022

Apr 11, 2022

SELL
$131.98 - $163.75 $3,299 - $4,093
-25 Reduced 0.66%
3,743 $607,000
Q4 2021

Jan 10, 2022

SELL
$107.43 - $135.93 $322 - $407
-3 Reduced 0.08%
3,768 $510,000
Q2 2021

Jul 12, 2021

SELL
$105.21 - $117.21 $5,260 - $5,860
-50 Reduced 1.31%
3,771 $425,000
Q4 2018

Jan 15, 2019

SELL
$77.85 - $96.01 $7,784 - $9,601
-100 Reduced 2.55%
3,821 $352,000
Q2 2018

Jul 16, 2018

SELL
$89.78 - $106.23 $26,934 - $31,869
-300 Reduced 7.11%
3,921 $363,000
Q1 2018

Apr 17, 2018

SELL
$92.01 - $123.21 $2,300 - $3,080
-25 Reduced 0.59%
4,221 $400,000
Q4 2017

Jan 17, 2018

SELL
$89.56 - $98.21 $26,868 - $29,462
-300 Reduced 6.6%
4,246 $411,000
Q3 2017

Oct 10, 2017

BUY
$69.85 - $89.22 $317,538 - $405,594
4,546
4,546 $404,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $304B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Lawson Kroeker Investment Management Inc Portfolio

Follow Lawson Kroeker Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lawson Kroeker Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Lawson Kroeker Investment Management Inc with notifications on news.